Adam C Reese

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi Inaccuracies in assignment of clinical stage for localized prostate cancer
    Adam C Reese
    Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143, USA
    Cancer 117:283-9. 2011
  2. ncbi Emphysematous cystitis
    Adam C Reese
    Department of Urology, School of Medicine, University of California, San Francisco, California 94143, USA
    Urology 75:1315-6. 2010
  3. ncbi Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized disease
    Adam C Reese
    Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA
    J Urol 184:114-9. 2010
  4. doi The quantitative Gleason score improves prostate cancer risk assessment
    Adam C Reese
    Department of Urology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94143 1695, USA
    Cancer 118:6046-54. 2012
  5. doi Natural history of untreated renal cell carcinoma with venous tumor thrombus
    Adam C Reese
    Department of Urology, University of California San Francisco, San Francisco, CA 94143, USA Electronic address
    Urol Oncol 31:1305-9. 2013
  6. doi Population based analysis of survival in patients with renal cell carcinoma and venous tumor thrombus
    Jared M Whitson
    Department of Urology, University of California, San Francisco, CA 94143, USA
    Urol Oncol 31:259-63. 2013
  7. doi Poor agreement of prostate specific antigen doubling times calculated using ultrasensitive versus standard prostate specific antigen values: important impact on risk assessment
    Adam C Reese
    Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California 94115, USA
    J Urol 186:2228-32. 2011
  8. doi Lymphadenectomy improves survival of patients with renal cell carcinoma and nodal metastases
    Jared M Whitson
    Department of Urology, University of California San Francisco, San Francisco, California 94143, USA
    J Urol 185:1615-20. 2011
  9. pmc Outcomes of active surveillance for men with intermediate-risk prostate cancer
    Matthew R Cooperberg
    University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA
    J Clin Oncol 29:228-34. 2011
  10. ncbi PSA updated: still relevant in the new millennium?
    Jay B Shah
    Department of Urology, Columbia University Medical Center, 161 Fort Washington Avenue, IP 11, New York, NY 10032, USA
    Eur Urol 47:427-32. 2005

Detail Information

Publications12

  1. doi Inaccuracies in assignment of clinical stage for localized prostate cancer
    Adam C Reese
    Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143, USA
    Cancer 117:283-9. 2011
    ..One explanation for this lack of predictive power may be the inaccurate application of staging criteria...
  2. ncbi Emphysematous cystitis
    Adam C Reese
    Department of Urology, School of Medicine, University of California, San Francisco, California 94143, USA
    Urology 75:1315-6. 2010
    ..A conservative treatment approach using antibiotics and bladder catheterization is typically successful, with a complication rate of only 18.8%...
  3. ncbi Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized disease
    Adam C Reese
    Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA
    J Urol 184:114-9. 2010
    ..We hypothesize that in the context of data available from a contemporary biopsy, clinical stage no longer offers meaningful independent prognostic information for clinically localized prostate cancer...
  4. doi The quantitative Gleason score improves prostate cancer risk assessment
    Adam C Reese
    Department of Urology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94143 1695, USA
    Cancer 118:6046-54. 2012
    ..They hypothesize that the qGS can improve prostate cancer risk stratification and help prevent the overtreatment of patients with clinically indolent tumors...
  5. doi Natural history of untreated renal cell carcinoma with venous tumor thrombus
    Adam C Reese
    Department of Urology, University of California San Francisco, San Francisco, CA 94143, USA Electronic address
    Urol Oncol 31:1305-9. 2013
    ..We aimed to describe the natural history of this disease, and to identify prognostic factors associated with disease-specific survival...
  6. doi Population based analysis of survival in patients with renal cell carcinoma and venous tumor thrombus
    Jared M Whitson
    Department of Urology, University of California, San Francisco, CA 94143, USA
    Urol Oncol 31:259-63. 2013
    ..To identify prognostic factors for renal cell carcinoma (RCC) with venous tumor thrombus (VTT) and determine the significance of thrombus level on survival...
  7. doi Poor agreement of prostate specific antigen doubling times calculated using ultrasensitive versus standard prostate specific antigen values: important impact on risk assessment
    Adam C Reese
    Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California 94115, USA
    J Urol 186:2228-32. 2011
    ..2 ng/ml) accurately reflects measures performed in the traditional range (prostate specific antigen greater than 0.2 ng/ml)...
  8. doi Lymphadenectomy improves survival of patients with renal cell carcinoma and nodal metastases
    Jared M Whitson
    Department of Urology, University of California San Francisco, San Francisco, California 94143, USA
    J Urol 185:1615-20. 2011
    ..In a population based cohort we determined whether an increase in the number of lymph nodes removed is associated with improved disease specific survival of patients with renal cell carcinoma treated with nephrectomy...
  9. pmc Outcomes of active surveillance for men with intermediate-risk prostate cancer
    Matthew R Cooperberg
    University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA
    J Clin Oncol 29:228-34. 2011
    ..Current risk stratification schema identify patients with low-risk disease who are presumed to be most suitable for AS. However, some men with higher risk disease also elect AS; outcomes for such men have not been widely reported...
  10. ncbi PSA updated: still relevant in the new millennium?
    Jay B Shah
    Department of Urology, Columbia University Medical Center, 161 Fort Washington Avenue, IP 11, New York, NY 10032, USA
    Eur Urol 47:427-32. 2005
  11. doi Factors associated with surgery in patients with renal cell carcinoma and venous tumor thrombus
    Jared M Whitson
    Department of Urology, University of California San Francisco, San Francisco, CA, USA
    BJU Int 107:729-34. 2011
    ..Little is known about the factors influencing the decision to pursue surgery versus conservative management in patients with RCC and venous tumour thrombus...
  12. pmc Omega-3 fatty acids, genetic variants in COX-2 and prostate cancer
    Adam C Reese
    Department of Urology, University of California San Francisco, CA 94158, USA
    J Nutrigenet Nutrigenomics 2:149-58. 2009
    ..Overall, results to date support the hypothesis that long-chain omega-3 PUFAs may impact prostate inflammation and carcinogenesis via the COX-2 enzymatic pathway...